NCT05314608View on ClinicalTrials.gov

Knee Related Subchondral Bone Lesions Treated With IOBP

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

November 17, 2021

Primary Completion Date

May 17, 2027

Study Completion Date

May 17, 2027

Conditions
Subchondral Cyst
Interventions
COMBINATION_PRODUCT

IntraOsseous BioPlasty® (IOBP®) Surgical Technique into the knee

Injection of a biologic mixture (BMC and allograft) into the subchondral bone lesion

Trial Locations (5)

15212

RECRUITING

Allegheny-Singer Research Institute, Pittsburgh

21801

RECRUITING

TidalHealth Peninsula Regional, Inc., Salisbury

32561

RECRUITING

Andrews Research and Education Foundation, Gulf Breeze

43201

RECRUITING

The Ohio State University, Columbus

80222

RECRUITING

University of Colorado Sports Medicine, Denver

Sponsors

Lead Sponsor

Arthrex, Inc.
All Listed Sponsors
lead

Arthrex, Inc.

INDUSTRY

NCT05314608 - Knee Related Subchondral Bone Lesions Treated With IOBP | Biotech Hunter | Biotech Hunter